Potential Impact of the Inflation Reduction Act

Download the report to find out about the Potential Impact of the Inflation Reduction Act from the US.

Potential Impact of the Inflation Reduction Act

The report provides a comprehensive analysis of:

  • IRA Background and Overview, including:

    • Timeline of Inflation Reduction Act (IRA) Provisions.

    • Price Negotiations

    • Other provisions, including price increases being indexed to inflation, cost sharing capped at $35 for insulin and eliminated for vaccines, and LIS eligibility expansion

  • Potential Outcomes of the IRA, including:

    • New Price Benchmarks

    • Increased Payer Management

    • Part D redesign impacts

    • Market and Patient impact

  • Considerations for Manufacturers

    • Manufacturers will need to consider the direct and indirect impact of price negotiations and change in payer behavior to address increased liability

    • Manufacturers should monitor the role that CMS may play in supporting plans and the downstream effects of the IRA on patients, providers, and pharmacies

For further information, please contact:

Mickey Popli

mickey.popli@windrosecg.com

Previous
Previous

Mark Kohler promoted to Senior Principal

Next
Next

New team members in the UK and Switzerland